The popularity of direct-to-consumer (DTC) genetic testing has increased steadily in recent years. But the growing use of these tests has also highlighted the need for validating and interpreting the tests’ results.
In an effort to address these and other challenges arising from the rapid growth of DTC genetic testing, digital health company My Gene Counsel is partnering with Ambry Genetics in a pilot program designed to confirm the results of DTC genetic tests and help people understand them. In particular, the companies are targeting people with a personal or family history of cancer and received negative DTC testing results.
To view the full article, click here.